Agilent Acquires GE Healthcare's Chemiluminescence Line to Bolster Gas Chromatographs | GenomeWeb
NEW YORK (GenomeWeb News) — Agilent Technologies has purchased the chemiluminescence product line from GE Healthcare’s Analytical Instruments segment, Agilent said today.
 
The deal includes intellectual property, sales, marketing, and manufacturing assets.
 
New products Agilent acquired through the deal include sulfur and nitrogen chemiluminescence detectors that Agilent said it will incorporate into its Chemical Analysis Solutions unit.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.